nodes	percent_of_prediction	percent_of_DWPC	metapath
Valproic Acid—UGT2B7—Epirubicin—uterine cancer	0.0736	0.133	CbGbCtD
Valproic Acid—SLC22A5—Dactinomycin—uterine cancer	0.0686	0.124	CbGbCtD
Valproic Acid—CYP2A6—Progesterone—uterine cancer	0.0658	0.119	CbGbCtD
Valproic Acid—CYP2C8—Medroxyprogesterone Acetate—uterine cancer	0.049	0.0884	CbGbCtD
Valproic Acid—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.0342	0.0616	CbGbCtD
Valproic Acid—CYP3A5—Progesterone—uterine cancer	0.0337	0.0609	CbGbCtD
Valproic Acid—CYP2C8—Progesterone—uterine cancer	0.0324	0.0585	CbGbCtD
Valproic Acid—CYP2C19—Progesterone—uterine cancer	0.0272	0.0491	CbGbCtD
Valproic Acid—PTGS1—Etoposide—uterine cancer	0.0252	0.0454	CbGbCtD
Valproic Acid—CYP1A2—Progesterone—uterine cancer	0.0251	0.0453	CbGbCtD
Valproic Acid—CYP2C9—Progesterone—uterine cancer	0.0226	0.0408	CbGbCtD
Valproic Acid—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0199	0.0358	CbGbCtD
Valproic Acid—CYP3A5—Etoposide—uterine cancer	0.0151	0.0272	CbGbCtD
Valproic Acid—CYP2C8—Etoposide—uterine cancer	0.0145	0.0262	CbGbCtD
Valproic Acid—CYP3A4—Progesterone—uterine cancer	0.0132	0.0237	CbGbCtD
Valproic Acid—CYP2B6—Doxorubicin—uterine cancer	0.0131	0.0236	CbGbCtD
Valproic Acid—CYP1A2—Etoposide—uterine cancer	0.0112	0.0203	CbGbCtD
Valproic Acid—CYP3A4—Etoposide—uterine cancer	0.00589	0.0106	CbGbCtD
Valproic Acid—HDAC2—oviduct—uterine cancer	0.00411	0.0385	CbGeAlD
Valproic Acid—CYP3A4—Doxorubicin—uterine cancer	0.00402	0.00725	CbGbCtD
Valproic Acid—UGT1A10—renal system—uterine cancer	0.00289	0.0271	CbGeAlD
Valproic Acid—HDAC2—exocrine gland—uterine cancer	0.00237	0.0223	CbGeAlD
Valproic Acid—ACADSB—myometrium—uterine cancer	0.00232	0.0217	CbGeAlD
Valproic Acid—UGT1A8—renal system—uterine cancer	0.00228	0.0214	CbGeAlD
Valproic Acid—OGDH—uterine cervix—uterine cancer	0.00227	0.0213	CbGeAlD
Valproic Acid—OGDH—decidua—uterine cancer	0.00216	0.0203	CbGeAlD
Valproic Acid—OGDH—renal system—uterine cancer	0.00212	0.0199	CbGeAlD
Valproic Acid—HDAC9—uterine cervix—uterine cancer	0.002	0.0188	CbGeAlD
Valproic Acid—HDAC2—Teniposide—Etoposide—uterine cancer	0.00195	0.73	CbGdCrCtD
Valproic Acid—HDAC9—decidua—uterine cancer	0.00191	0.0179	CbGeAlD
Valproic Acid—OGDH—uterus—uterine cancer	0.00189	0.0177	CbGeAlD
Valproic Acid—ACADSB—uterine cervix—uterine cancer	0.0018	0.0169	CbGeAlD
Valproic Acid—UGT1A4—renal system—uterine cancer	0.00173	0.0162	CbGeAlD
Valproic Acid—ACADSB—decidua—uterine cancer	0.00172	0.0161	CbGeAlD
Valproic Acid—OGDH—female reproductive system—uterine cancer	0.0017	0.016	CbGeAlD
Valproic Acid—ACADSB—renal system—uterine cancer	0.00169	0.0158	CbGeAlD
Valproic Acid—HDAC9—uterus—uterine cancer	0.00167	0.0156	CbGeAlD
Valproic Acid—PTGS1—oviduct—uterine cancer	0.00164	0.0154	CbGeAlD
Valproic Acid—ACADSB—endometrium—uterine cancer	0.00163	0.0153	CbGeAlD
Valproic Acid—ALDH5A1—uterine cervix—uterine cancer	0.00159	0.0149	CbGeAlD
Valproic Acid—ACADSB—mammalian vulva—uterine cancer	0.00158	0.0148	CbGeAlD
Valproic Acid—OGDH—female gonad—uterine cancer	0.00155	0.0145	CbGeAlD
Valproic Acid—UGT2B15—female reproductive system—uterine cancer	0.00153	0.0144	CbGeAlD
Valproic Acid—ALDH5A1—decidua—uterine cancer	0.00151	0.0142	CbGeAlD
Valproic Acid—ACADSB—uterus—uterine cancer	0.0015	0.0141	CbGeAlD
Valproic Acid—HDAC9—female reproductive system—uterine cancer	0.0015	0.0141	CbGeAlD
Valproic Acid—ALDH5A1—renal system—uterine cancer	0.00149	0.0139	CbGeAlD
Valproic Acid—UGT1A9—renal system—uterine cancer	0.00145	0.0136	CbGeAlD
Valproic Acid—HDAC9—female gonad—uterine cancer	0.00136	0.0128	CbGeAlD
Valproic Acid—CYP2C18—uterine cervix—uterine cancer	0.00136	0.0127	CbGeAlD
Valproic Acid—ACADSB—female reproductive system—uterine cancer	0.00135	0.0127	CbGeAlD
Valproic Acid—ABAT—renal system—uterine cancer	0.00127	0.0119	CbGeAlD
Valproic Acid—ACADSB—female gonad—uterine cancer	0.00123	0.0115	CbGeAlD
Valproic Acid—ACADSB—vagina—uterine cancer	0.00122	0.0115	CbGeAlD
Valproic Acid—ALDH5A1—female reproductive system—uterine cancer	0.00119	0.0112	CbGeAlD
Valproic Acid—CYP2C18—mammalian vulva—uterine cancer	0.00119	0.0111	CbGeAlD
Valproic Acid—UGT2B7—renal system—uterine cancer	0.00117	0.011	CbGeAlD
Valproic Acid—SLC22A7—renal system—uterine cancer	0.00111	0.0104	CbGeAlD
Valproic Acid—PTGS1—artery—uterine cancer	0.00108	0.0102	CbGeAlD
Valproic Acid—ALDH5A1—female gonad—uterine cancer	0.00108	0.0102	CbGeAlD
Valproic Acid—ALDH5A1—vagina—uterine cancer	0.00108	0.0101	CbGeAlD
Valproic Acid—HDAC2—epithelium—uterine cancer	0.00103	0.00968	CbGeAlD
Valproic Acid—HDAC2—uterine cervix—uterine cancer	0.00102	0.0096	CbGeAlD
Valproic Acid—OGDH—lymph node—uterine cancer	0.000995	0.00933	CbGeAlD
Valproic Acid—HDAC2—smooth muscle tissue—uterine cancer	0.000994	0.00933	CbGeAlD
Valproic Acid—HDAC2—decidua—uterine cancer	0.000975	0.00914	CbGeAlD
Valproic Acid—HDAC2—renal system—uterine cancer	0.000957	0.00898	CbGeAlD
Valproic Acid—UGT2B7—female reproductive system—uterine cancer	0.000937	0.00879	CbGeAlD
Valproic Acid—ABAT—female gonad—uterine cancer	0.000926	0.00869	CbGeAlD
Valproic Acid—HDAC2—endometrium—uterine cancer	0.000925	0.00868	CbGeAlD
Valproic Acid—ABAT—vagina—uterine cancer	0.00092	0.00863	CbGeAlD
Valproic Acid—CYP2C18—vagina—uterine cancer	0.000919	0.00862	CbGeAlD
Valproic Acid—SLC16A1—epithelium—uterine cancer	0.000917	0.0086	CbGeAlD
Valproic Acid—HDAC9—lymph node—uterine cancer	0.000877	0.00823	CbGeAlD
Valproic Acid—SLC16A1—decidua—uterine cancer	0.000866	0.00813	CbGeAlD
Valproic Acid—HDAC2—uterus—uterine cancer	0.000853	0.008	CbGeAlD
Valproic Acid—SLC16A1—renal system—uterine cancer	0.000851	0.00798	CbGeAlD
Valproic Acid—SLC16A1—endometrium—uterine cancer	0.000822	0.00771	CbGeAlD
Valproic Acid—ACADSB—lymph node—uterine cancer	0.00079	0.00741	CbGeAlD
Valproic Acid—HDAC2—female reproductive system—uterine cancer	0.000767	0.00719	CbGeAlD
Valproic Acid—SLC16A1—uterus—uterine cancer	0.000758	0.00711	CbGeAlD
Valproic Acid—HDAC2—Levonorgestrel—Progesterone—uterine cancer	0.000719	0.269	CbGdCrCtD
Valproic Acid—HDAC2—female gonad—uterine cancer	0.000698	0.00654	CbGeAlD
Valproic Acid—ALDH5A1—lymph node—uterine cancer	0.000696	0.00653	CbGeAlD
Valproic Acid—HDAC2—vagina—uterine cancer	0.000693	0.0065	CbGeAlD
Valproic Acid—SLC16A1—female reproductive system—uterine cancer	0.000681	0.00639	CbGeAlD
Valproic Acid—SLC22A5—myometrium—uterine cancer	0.000668	0.00626	CbGeAlD
Valproic Acid—SLC22A8—renal system—uterine cancer	0.000643	0.00603	CbGeAlD
Valproic Acid—SLC16A1—female gonad—uterine cancer	0.00062	0.00581	CbGeAlD
Valproic Acid—CYP2A6—vagina—uterine cancer	0.000607	0.00569	CbGeAlD
Valproic Acid—ABAT—lymph node—uterine cancer	0.000595	0.00558	CbGeAlD
Valproic Acid—SLC22A5—uterine cervix—uterine cancer	0.000519	0.00487	CbGeAlD
Valproic Acid—SLC22A5—renal system—uterine cancer	0.000486	0.00456	CbGeAlD
Valproic Acid—CYP2C8—renal system—uterine cancer	0.00047	0.00441	CbGeAlD
Valproic Acid—SLC22A5—endometrium—uterine cancer	0.00047	0.00441	CbGeAlD
Valproic Acid—CYP2C8—endometrium—uterine cancer	0.000455	0.00427	CbGeAlD
Valproic Acid—CYP3A5—uterine cervix—uterine cancer	0.000454	0.00426	CbGeAlD
Valproic Acid—HDAC2—lymph node—uterine cancer	0.000448	0.00421	CbGeAlD
Valproic Acid—CYP1A2—renal system—uterine cancer	0.00044	0.00413	CbGeAlD
Valproic Acid—CYP3A5—renal system—uterine cancer	0.000425	0.00398	CbGeAlD
Valproic Acid—CYP2B6—renal system—uterine cancer	0.000422	0.00396	CbGeAlD
Valproic Acid—PTGS1—epithelium—uterine cancer	0.000411	0.00386	CbGeAlD
Valproic Acid—PTGS1—uterine cervix—uterine cancer	0.000408	0.00383	CbGeAlD
Valproic Acid—SLC16A1—lymph node—uterine cancer	0.000398	0.00374	CbGeAlD
Valproic Acid—PTGS1—smooth muscle tissue—uterine cancer	0.000396	0.00372	CbGeAlD
Valproic Acid—CYP2C19—vagina—uterine cancer	0.00039	0.00366	CbGeAlD
Valproic Acid—SLC22A5—female reproductive system—uterine cancer	0.000389	0.00365	CbGeAlD
Valproic Acid—PTGS1—renal system—uterine cancer	0.000382	0.00358	CbGeAlD
Valproic Acid—CYP2C8—female reproductive system—uterine cancer	0.000377	0.00353	CbGeAlD
Valproic Acid—PTGS1—endometrium—uterine cancer	0.000369	0.00346	CbGeAlD
Valproic Acid—PTGS1—mammalian vulva—uterine cancer	0.000357	0.00335	CbGeAlD
Valproic Acid—SLC22A5—female gonad—uterine cancer	0.000354	0.00332	CbGeAlD
Valproic Acid—SLC22A5—vagina—uterine cancer	0.000352	0.0033	CbGeAlD
Valproic Acid—CYP2C8—vagina—uterine cancer	0.000341	0.0032	CbGeAlD
Valproic Acid—PTGS1—uterus—uterine cancer	0.00034	0.00319	CbGeAlD
Valproic Acid—CYP2B6—female reproductive system—uterine cancer	0.000338	0.00317	CbGeAlD
Valproic Acid—CYP2C9—female reproductive system—uterine cancer	0.000335	0.00314	CbGeAlD
Valproic Acid—CYP3A4—renal system—uterine cancer	0.000319	0.00299	CbGeAlD
Valproic Acid—CYP3A5—female gonad—uterine cancer	0.000309	0.0029	CbGeAlD
Valproic Acid—CYP3A5—vagina—uterine cancer	0.000308	0.00289	CbGeAlD
Valproic Acid—CYP2B6—vagina—uterine cancer	0.000306	0.00287	CbGeAlD
Valproic Acid—PTGS1—female reproductive system—uterine cancer	0.000306	0.00287	CbGeAlD
Valproic Acid—PTGS1—female gonad—uterine cancer	0.000278	0.00261	CbGeAlD
Valproic Acid—PTGS1—vagina—uterine cancer	0.000276	0.00259	CbGeAlD
Valproic Acid—CYP3A4—female reproductive system—uterine cancer	0.000255	0.00239	CbGeAlD
Valproic Acid—SLC22A5—lymph node—uterine cancer	0.000228	0.00214	CbGeAlD
Valproic Acid—PTGS1—lymph node—uterine cancer	0.000179	0.00168	CbGeAlD
Valproic Acid—Dysphagia—Epirubicin—uterine cancer	0.000128	0.00056	CcSEcCtD
Valproic Acid—Thrombocytopenia—Etoposide—uterine cancer	0.000127	0.000556	CcSEcCtD
Valproic Acid—Tachycardia—Etoposide—uterine cancer	0.000127	0.000554	CcSEcCtD
Valproic Acid—Eosinophilia—Epirubicin—uterine cancer	0.000127	0.000554	CcSEcCtD
Valproic Acid—Skin disorder—Etoposide—uterine cancer	0.000126	0.000552	CcSEcCtD
Valproic Acid—Dry skin—Doxorubicin—uterine cancer	0.000126	0.000549	CcSEcCtD
Valproic Acid—Hyperhidrosis—Etoposide—uterine cancer	0.000126	0.000549	CcSEcCtD
Valproic Acid—Pancreatitis—Epirubicin—uterine cancer	0.000126	0.000549	CcSEcCtD
Valproic Acid—Orthostatic hypotension—Doxorubicin—uterine cancer	0.000125	0.000547	CcSEcCtD
Valproic Acid—Abdominal pain upper—Doxorubicin—uterine cancer	0.000125	0.000547	CcSEcCtD
Valproic Acid—Breast disorder—Doxorubicin—uterine cancer	0.000124	0.000542	CcSEcCtD
Valproic Acid—Anorexia—Etoposide—uterine cancer	0.000124	0.000541	CcSEcCtD
Valproic Acid—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	0.000124	0.00054	CcSEcCtD
Valproic Acid—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	0.000124	0.00054	CcSEcCtD
Valproic Acid—Bronchitis—Epirubicin—uterine cancer	0.000123	0.000538	CcSEcCtD
Valproic Acid—Diarrhoea—Dactinomycin—uterine cancer	0.000123	0.000537	CcSEcCtD
Valproic Acid—Pancytopenia—Epirubicin—uterine cancer	0.000122	0.000532	CcSEcCtD
Valproic Acid—Hypotension—Etoposide—uterine cancer	0.000122	0.000531	CcSEcCtD
Valproic Acid—Alanine aminotransferase increased—Doxorubicin—uterine cancer	0.000121	0.000529	CcSEcCtD
Valproic Acid—Muscular weakness—Doxorubicin—uterine cancer	0.000121	0.000529	CcSEcCtD
Valproic Acid—Neutropenia—Epirubicin—uterine cancer	0.00012	0.000523	CcSEcCtD
Valproic Acid—Dysuria—Epirubicin—uterine cancer	0.00012	0.000523	CcSEcCtD
Valproic Acid—Influenza—Doxorubicin—uterine cancer	0.000119	0.000518	CcSEcCtD
Valproic Acid—Dysphagia—Doxorubicin—uterine cancer	0.000119	0.000518	CcSEcCtD
Valproic Acid—Pollakiuria—Epirubicin—uterine cancer	0.000118	0.000517	CcSEcCtD
Valproic Acid—Eosinophilia—Doxorubicin—uterine cancer	0.000118	0.000513	CcSEcCtD
Valproic Acid—Photosensitivity reaction—Epirubicin—uterine cancer	0.000117	0.000511	CcSEcCtD
Valproic Acid—Paraesthesia—Etoposide—uterine cancer	0.000117	0.00051	CcSEcCtD
Valproic Acid—Weight increased—Epirubicin—uterine cancer	0.000117	0.000509	CcSEcCtD
Valproic Acid—Pancreatitis—Doxorubicin—uterine cancer	0.000116	0.000508	CcSEcCtD
Valproic Acid—Weight decreased—Epirubicin—uterine cancer	0.000116	0.000506	CcSEcCtD
Valproic Acid—Dyspnoea—Etoposide—uterine cancer	0.000116	0.000506	CcSEcCtD
Valproic Acid—Somnolence—Etoposide—uterine cancer	0.000116	0.000505	CcSEcCtD
Valproic Acid—Pneumonia—Epirubicin—uterine cancer	0.000115	0.000502	CcSEcCtD
Valproic Acid—Drowsiness—Epirubicin—uterine cancer	0.000114	0.000499	CcSEcCtD
Valproic Acid—Vomiting—Dactinomycin—uterine cancer	0.000114	0.000499	CcSEcCtD
Valproic Acid—Bronchitis—Doxorubicin—uterine cancer	0.000114	0.000498	CcSEcCtD
Valproic Acid—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.000113	0.000495	CcSEcCtD
Valproic Acid—Rash—Dactinomycin—uterine cancer	0.000113	0.000495	CcSEcCtD
Valproic Acid—Decreased appetite—Etoposide—uterine cancer	0.000113	0.000494	CcSEcCtD
Valproic Acid—Pancytopenia—Doxorubicin—uterine cancer	0.000113	0.000492	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Etoposide—uterine cancer	0.000112	0.00049	CcSEcCtD
Valproic Acid—Fatigue—Etoposide—uterine cancer	0.000112	0.00049	CcSEcCtD
Valproic Acid—Stomatitis—Epirubicin—uterine cancer	0.000111	0.000486	CcSEcCtD
Valproic Acid—Pain—Etoposide—uterine cancer	0.000111	0.000486	CcSEcCtD
Valproic Acid—Constipation—Etoposide—uterine cancer	0.000111	0.000486	CcSEcCtD
Valproic Acid—Urinary tract infection—Epirubicin—uterine cancer	0.000111	0.000485	CcSEcCtD
Valproic Acid—Conjunctivitis—Epirubicin—uterine cancer	0.000111	0.000485	CcSEcCtD
Valproic Acid—Dysuria—Doxorubicin—uterine cancer	0.000111	0.000484	CcSEcCtD
Valproic Acid—Neutropenia—Doxorubicin—uterine cancer	0.000111	0.000484	CcSEcCtD
Valproic Acid—Sweating—Epirubicin—uterine cancer	0.00011	0.000478	CcSEcCtD
Valproic Acid—Pollakiuria—Doxorubicin—uterine cancer	0.00011	0.000478	CcSEcCtD
Valproic Acid—Photosensitivity reaction—Doxorubicin—uterine cancer	0.000108	0.000473	CcSEcCtD
Valproic Acid—Hepatobiliary disease—Epirubicin—uterine cancer	0.000108	0.000472	CcSEcCtD
Valproic Acid—Weight increased—Doxorubicin—uterine cancer	0.000108	0.000471	CcSEcCtD
Valproic Acid—Epistaxis—Epirubicin—uterine cancer	0.000108	0.000471	CcSEcCtD
Valproic Acid—Weight decreased—Doxorubicin—uterine cancer	0.000107	0.000469	CcSEcCtD
Valproic Acid—Sinusitis—Epirubicin—uterine cancer	0.000107	0.000468	CcSEcCtD
Valproic Acid—Feeling abnormal—Etoposide—uterine cancer	0.000107	0.000468	CcSEcCtD
Valproic Acid—Nausea—Dactinomycin—uterine cancer	0.000107	0.000466	CcSEcCtD
Valproic Acid—Agranulocytosis—Epirubicin—uterine cancer	0.000107	0.000466	CcSEcCtD
Valproic Acid—Pneumonia—Doxorubicin—uterine cancer	0.000106	0.000464	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Etoposide—uterine cancer	0.000106	0.000464	CcSEcCtD
Valproic Acid—Drowsiness—Doxorubicin—uterine cancer	0.000106	0.000462	CcSEcCtD
Valproic Acid—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.000105	0.000458	CcSEcCtD
Valproic Acid—Bradycardia—Epirubicin—uterine cancer	0.000105	0.000456	CcSEcCtD
Valproic Acid—Urticaria—Etoposide—uterine cancer	0.000103	0.000451	CcSEcCtD
Valproic Acid—Haemoglobin—Epirubicin—uterine cancer	0.000103	0.00045	CcSEcCtD
Valproic Acid—Stomatitis—Doxorubicin—uterine cancer	0.000103	0.00045	CcSEcCtD
Valproic Acid—Rhinitis—Epirubicin—uterine cancer	0.000103	0.000449	CcSEcCtD
Valproic Acid—Body temperature increased—Etoposide—uterine cancer	0.000103	0.000449	CcSEcCtD
Valproic Acid—Abdominal pain—Etoposide—uterine cancer	0.000103	0.000449	CcSEcCtD
Valproic Acid—Conjunctivitis—Doxorubicin—uterine cancer	0.000103	0.000449	CcSEcCtD
Valproic Acid—Urinary tract infection—Doxorubicin—uterine cancer	0.000103	0.000449	CcSEcCtD
Valproic Acid—Haemorrhage—Epirubicin—uterine cancer	0.000103	0.000448	CcSEcCtD
Valproic Acid—Hypoaesthesia—Epirubicin—uterine cancer	0.000102	0.000446	CcSEcCtD
Valproic Acid—Pharyngitis—Epirubicin—uterine cancer	0.000102	0.000445	CcSEcCtD
Valproic Acid—Sweating—Doxorubicin—uterine cancer	0.000101	0.000443	CcSEcCtD
Valproic Acid—Urinary tract disorder—Epirubicin—uterine cancer	0.000101	0.000442	CcSEcCtD
Valproic Acid—Oedema peripheral—Epirubicin—uterine cancer	0.000101	0.000441	CcSEcCtD
Valproic Acid—Connective tissue disorder—Epirubicin—uterine cancer	0.000101	0.00044	CcSEcCtD
Valproic Acid—Urethral disorder—Epirubicin—uterine cancer	0.000101	0.000439	CcSEcCtD
Valproic Acid—Hepatobiliary disease—Doxorubicin—uterine cancer	0.0001	0.000437	CcSEcCtD
Valproic Acid—Epistaxis—Doxorubicin—uterine cancer	9.98e-05	0.000436	CcSEcCtD
Valproic Acid—Sinusitis—Doxorubicin—uterine cancer	9.93e-05	0.000433	CcSEcCtD
Valproic Acid—Visual impairment—Epirubicin—uterine cancer	9.89e-05	0.000432	CcSEcCtD
Valproic Acid—Agranulocytosis—Doxorubicin—uterine cancer	9.87e-05	0.000431	CcSEcCtD
Valproic Acid—Erythema multiforme—Epirubicin—uterine cancer	9.71e-05	0.000424	CcSEcCtD
Valproic Acid—Bradycardia—Doxorubicin—uterine cancer	9.67e-05	0.000422	CcSEcCtD
Valproic Acid—Eye disorder—Epirubicin—uterine cancer	9.59e-05	0.000419	CcSEcCtD
Valproic Acid—Hypersensitivity—Etoposide—uterine cancer	9.59e-05	0.000418	CcSEcCtD
Valproic Acid—Tinnitus—Epirubicin—uterine cancer	9.57e-05	0.000418	CcSEcCtD
Valproic Acid—Haemoglobin—Doxorubicin—uterine cancer	9.55e-05	0.000417	CcSEcCtD
Valproic Acid—Rhinitis—Doxorubicin—uterine cancer	9.52e-05	0.000416	CcSEcCtD
Valproic Acid—Haemorrhage—Doxorubicin—uterine cancer	9.5e-05	0.000415	CcSEcCtD
Valproic Acid—Hypoaesthesia—Doxorubicin—uterine cancer	9.45e-05	0.000412	CcSEcCtD
Valproic Acid—Pharyngitis—Doxorubicin—uterine cancer	9.43e-05	0.000411	CcSEcCtD
Valproic Acid—Urinary tract disorder—Doxorubicin—uterine cancer	9.38e-05	0.000409	CcSEcCtD
Valproic Acid—Oedema peripheral—Doxorubicin—uterine cancer	9.36e-05	0.000408	CcSEcCtD
Valproic Acid—Asthenia—Etoposide—uterine cancer	9.34e-05	0.000407	CcSEcCtD
Valproic Acid—Connective tissue disorder—Doxorubicin—uterine cancer	9.33e-05	0.000407	CcSEcCtD
Valproic Acid—Angiopathy—Epirubicin—uterine cancer	9.31e-05	0.000406	CcSEcCtD
Valproic Acid—Urethral disorder—Doxorubicin—uterine cancer	9.31e-05	0.000406	CcSEcCtD
Valproic Acid—Immune system disorder—Epirubicin—uterine cancer	9.27e-05	0.000405	CcSEcCtD
Valproic Acid—Mediastinal disorder—Epirubicin—uterine cancer	9.25e-05	0.000404	CcSEcCtD
Valproic Acid—Chills—Epirubicin—uterine cancer	9.21e-05	0.000402	CcSEcCtD
Valproic Acid—Pruritus—Etoposide—uterine cancer	9.21e-05	0.000402	CcSEcCtD
Valproic Acid—Arrhythmia—Epirubicin—uterine cancer	9.17e-05	0.0004	CcSEcCtD
Valproic Acid—Visual impairment—Doxorubicin—uterine cancer	9.15e-05	0.0004	CcSEcCtD
Valproic Acid—Alopecia—Epirubicin—uterine cancer	9.07e-05	0.000396	CcSEcCtD
Valproic Acid—Mental disorder—Epirubicin—uterine cancer	8.99e-05	0.000393	CcSEcCtD
Valproic Acid—Erythema multiforme—Doxorubicin—uterine cancer	8.98e-05	0.000392	CcSEcCtD
Valproic Acid—Malnutrition—Epirubicin—uterine cancer	8.94e-05	0.00039	CcSEcCtD
Valproic Acid—Diarrhoea—Etoposide—uterine cancer	8.9e-05	0.000389	CcSEcCtD
Valproic Acid—Eye disorder—Doxorubicin—uterine cancer	8.88e-05	0.000387	CcSEcCtD
Valproic Acid—Tinnitus—Doxorubicin—uterine cancer	8.86e-05	0.000387	CcSEcCtD
Valproic Acid—Flatulence—Epirubicin—uterine cancer	8.81e-05	0.000384	CcSEcCtD
Valproic Acid—Tension—Epirubicin—uterine cancer	8.77e-05	0.000383	CcSEcCtD
Valproic Acid—Dysgeusia—Epirubicin—uterine cancer	8.75e-05	0.000382	CcSEcCtD
Valproic Acid—Nervousness—Epirubicin—uterine cancer	8.68e-05	0.000379	CcSEcCtD
Valproic Acid—Back pain—Epirubicin—uterine cancer	8.64e-05	0.000377	CcSEcCtD
Valproic Acid—Angiopathy—Doxorubicin—uterine cancer	8.62e-05	0.000376	CcSEcCtD
Valproic Acid—Dizziness—Etoposide—uterine cancer	8.6e-05	0.000376	CcSEcCtD
Valproic Acid—Muscle spasms—Epirubicin—uterine cancer	8.59e-05	0.000375	CcSEcCtD
Valproic Acid—Immune system disorder—Doxorubicin—uterine cancer	8.58e-05	0.000374	CcSEcCtD
Valproic Acid—Mediastinal disorder—Doxorubicin—uterine cancer	8.56e-05	0.000374	CcSEcCtD
Valproic Acid—Chills—Doxorubicin—uterine cancer	8.52e-05	0.000372	CcSEcCtD
Valproic Acid—Arrhythmia—Doxorubicin—uterine cancer	8.49e-05	0.00037	CcSEcCtD
Valproic Acid—Vision blurred—Epirubicin—uterine cancer	8.42e-05	0.000368	CcSEcCtD
Valproic Acid—Alopecia—Doxorubicin—uterine cancer	8.39e-05	0.000366	CcSEcCtD
Valproic Acid—Mental disorder—Doxorubicin—uterine cancer	8.32e-05	0.000363	CcSEcCtD
Valproic Acid—Ill-defined disorder—Epirubicin—uterine cancer	8.29e-05	0.000362	CcSEcCtD
Valproic Acid—Vomiting—Etoposide—uterine cancer	8.27e-05	0.000361	CcSEcCtD
Valproic Acid—Malnutrition—Doxorubicin—uterine cancer	8.27e-05	0.000361	CcSEcCtD
Valproic Acid—Anaemia—Epirubicin—uterine cancer	8.26e-05	0.00036	CcSEcCtD
Valproic Acid—Agitation—Epirubicin—uterine cancer	8.21e-05	0.000358	CcSEcCtD
Valproic Acid—Rash—Etoposide—uterine cancer	8.2e-05	0.000358	CcSEcCtD
Valproic Acid—Dermatitis—Etoposide—uterine cancer	8.2e-05	0.000358	CcSEcCtD
Valproic Acid—Headache—Etoposide—uterine cancer	8.15e-05	0.000356	CcSEcCtD
Valproic Acid—Flatulence—Doxorubicin—uterine cancer	8.15e-05	0.000356	CcSEcCtD
Valproic Acid—Tension—Doxorubicin—uterine cancer	8.11e-05	0.000354	CcSEcCtD
Valproic Acid—Dysgeusia—Doxorubicin—uterine cancer	8.1e-05	0.000353	CcSEcCtD
Valproic Acid—Malaise—Epirubicin—uterine cancer	8.06e-05	0.000352	CcSEcCtD
Valproic Acid—Nervousness—Doxorubicin—uterine cancer	8.03e-05	0.00035	CcSEcCtD
Valproic Acid—Vertigo—Epirubicin—uterine cancer	8.03e-05	0.00035	CcSEcCtD
Valproic Acid—Leukopenia—Epirubicin—uterine cancer	8e-05	0.000349	CcSEcCtD
Valproic Acid—Back pain—Doxorubicin—uterine cancer	8e-05	0.000349	CcSEcCtD
Valproic Acid—Muscle spasms—Doxorubicin—uterine cancer	7.95e-05	0.000347	CcSEcCtD
Valproic Acid—Palpitations—Epirubicin—uterine cancer	7.9e-05	0.000345	CcSEcCtD
Valproic Acid—Cough—Epirubicin—uterine cancer	7.8e-05	0.00034	CcSEcCtD
Valproic Acid—Vision blurred—Doxorubicin—uterine cancer	7.79e-05	0.00034	CcSEcCtD
Valproic Acid—Nausea—Etoposide—uterine cancer	7.73e-05	0.000337	CcSEcCtD
Valproic Acid—Hypertension—Epirubicin—uterine cancer	7.72e-05	0.000337	CcSEcCtD
Valproic Acid—Ill-defined disorder—Doxorubicin—uterine cancer	7.67e-05	0.000335	CcSEcCtD
Valproic Acid—Anaemia—Doxorubicin—uterine cancer	7.64e-05	0.000334	CcSEcCtD
Valproic Acid—Arthralgia—Epirubicin—uterine cancer	7.61e-05	0.000332	CcSEcCtD
Valproic Acid—Chest pain—Epirubicin—uterine cancer	7.61e-05	0.000332	CcSEcCtD
Valproic Acid—Myalgia—Epirubicin—uterine cancer	7.61e-05	0.000332	CcSEcCtD
Valproic Acid—Agitation—Doxorubicin—uterine cancer	7.6e-05	0.000332	CcSEcCtD
Valproic Acid—Anxiety—Epirubicin—uterine cancer	7.58e-05	0.000331	CcSEcCtD
Valproic Acid—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	7.56e-05	0.00033	CcSEcCtD
Valproic Acid—Discomfort—Epirubicin—uterine cancer	7.52e-05	0.000328	CcSEcCtD
Valproic Acid—Malaise—Doxorubicin—uterine cancer	7.46e-05	0.000325	CcSEcCtD
Valproic Acid—Dry mouth—Epirubicin—uterine cancer	7.44e-05	0.000325	CcSEcCtD
Valproic Acid—Vertigo—Doxorubicin—uterine cancer	7.43e-05	0.000324	CcSEcCtD
Valproic Acid—Leukopenia—Doxorubicin—uterine cancer	7.4e-05	0.000323	CcSEcCtD
Valproic Acid—Confusional state—Epirubicin—uterine cancer	7.35e-05	0.000321	CcSEcCtD
Valproic Acid—Palpitations—Doxorubicin—uterine cancer	7.31e-05	0.000319	CcSEcCtD
Valproic Acid—Anaphylactic shock—Epirubicin—uterine cancer	7.29e-05	0.000318	CcSEcCtD
Valproic Acid—Oedema—Epirubicin—uterine cancer	7.29e-05	0.000318	CcSEcCtD
Valproic Acid—Infection—Epirubicin—uterine cancer	7.25e-05	0.000316	CcSEcCtD
Valproic Acid—Cough—Doxorubicin—uterine cancer	7.22e-05	0.000315	CcSEcCtD
Valproic Acid—Nervous system disorder—Epirubicin—uterine cancer	7.15e-05	0.000312	CcSEcCtD
Valproic Acid—Thrombocytopenia—Epirubicin—uterine cancer	7.14e-05	0.000312	CcSEcCtD
Valproic Acid—Hypertension—Doxorubicin—uterine cancer	7.14e-05	0.000312	CcSEcCtD
Valproic Acid—Tachycardia—Epirubicin—uterine cancer	7.12e-05	0.000311	CcSEcCtD
Valproic Acid—Skin disorder—Epirubicin—uterine cancer	7.08e-05	0.000309	CcSEcCtD
Valproic Acid—Hyperhidrosis—Epirubicin—uterine cancer	7.05e-05	0.000308	CcSEcCtD
Valproic Acid—Chest pain—Doxorubicin—uterine cancer	7.04e-05	0.000307	CcSEcCtD
Valproic Acid—Myalgia—Doxorubicin—uterine cancer	7.04e-05	0.000307	CcSEcCtD
Valproic Acid—Arthralgia—Doxorubicin—uterine cancer	7.04e-05	0.000307	CcSEcCtD
Valproic Acid—Anxiety—Doxorubicin—uterine cancer	7.02e-05	0.000306	CcSEcCtD
Valproic Acid—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	6.99e-05	0.000305	CcSEcCtD
Valproic Acid—Discomfort—Doxorubicin—uterine cancer	6.96e-05	0.000304	CcSEcCtD
Valproic Acid—Anorexia—Epirubicin—uterine cancer	6.95e-05	0.000303	CcSEcCtD
Valproic Acid—Dry mouth—Doxorubicin—uterine cancer	6.89e-05	0.0003	CcSEcCtD
Valproic Acid—Hypotension—Epirubicin—uterine cancer	6.82e-05	0.000297	CcSEcCtD
Valproic Acid—Confusional state—Doxorubicin—uterine cancer	6.8e-05	0.000297	CcSEcCtD
Valproic Acid—Oedema—Doxorubicin—uterine cancer	6.75e-05	0.000295	CcSEcCtD
Valproic Acid—Anaphylactic shock—Doxorubicin—uterine cancer	6.75e-05	0.000295	CcSEcCtD
Valproic Acid—Infection—Doxorubicin—uterine cancer	6.7e-05	0.000293	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Epirubicin—uterine cancer	6.65e-05	0.00029	CcSEcCtD
Valproic Acid—Nervous system disorder—Doxorubicin—uterine cancer	6.62e-05	0.000289	CcSEcCtD
Valproic Acid—Thrombocytopenia—Doxorubicin—uterine cancer	6.61e-05	0.000288	CcSEcCtD
Valproic Acid—Insomnia—Epirubicin—uterine cancer	6.6e-05	0.000288	CcSEcCtD
Valproic Acid—Tachycardia—Doxorubicin—uterine cancer	6.59e-05	0.000287	CcSEcCtD
Valproic Acid—Skin disorder—Doxorubicin—uterine cancer	6.56e-05	0.000286	CcSEcCtD
Valproic Acid—Paraesthesia—Epirubicin—uterine cancer	6.55e-05	0.000286	CcSEcCtD
Valproic Acid—Hyperhidrosis—Doxorubicin—uterine cancer	6.52e-05	0.000285	CcSEcCtD
Valproic Acid—Dyspnoea—Epirubicin—uterine cancer	6.5e-05	0.000284	CcSEcCtD
Valproic Acid—Somnolence—Epirubicin—uterine cancer	6.48e-05	0.000283	CcSEcCtD
Valproic Acid—Anorexia—Doxorubicin—uterine cancer	6.43e-05	0.000281	CcSEcCtD
Valproic Acid—Dyspepsia—Epirubicin—uterine cancer	6.42e-05	0.00028	CcSEcCtD
Valproic Acid—Decreased appetite—Epirubicin—uterine cancer	6.34e-05	0.000277	CcSEcCtD
Valproic Acid—Hypotension—Doxorubicin—uterine cancer	6.31e-05	0.000275	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Epirubicin—uterine cancer	6.3e-05	0.000275	CcSEcCtD
Valproic Acid—Fatigue—Epirubicin—uterine cancer	6.29e-05	0.000274	CcSEcCtD
Valproic Acid—Constipation—Epirubicin—uterine cancer	6.24e-05	0.000272	CcSEcCtD
Valproic Acid—Pain—Epirubicin—uterine cancer	6.24e-05	0.000272	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Doxorubicin—uterine cancer	6.15e-05	0.000268	CcSEcCtD
Valproic Acid—Insomnia—Doxorubicin—uterine cancer	6.1e-05	0.000266	CcSEcCtD
Valproic Acid—Paraesthesia—Doxorubicin—uterine cancer	6.06e-05	0.000264	CcSEcCtD
Valproic Acid—Dyspnoea—Doxorubicin—uterine cancer	6.02e-05	0.000263	CcSEcCtD
Valproic Acid—Feeling abnormal—Epirubicin—uterine cancer	6.01e-05	0.000262	CcSEcCtD
Valproic Acid—Somnolence—Doxorubicin—uterine cancer	6e-05	0.000262	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Epirubicin—uterine cancer	5.96e-05	0.00026	CcSEcCtD
Valproic Acid—Dyspepsia—Doxorubicin—uterine cancer	5.94e-05	0.000259	CcSEcCtD
Valproic Acid—Decreased appetite—Doxorubicin—uterine cancer	5.87e-05	0.000256	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Doxorubicin—uterine cancer	5.83e-05	0.000254	CcSEcCtD
Valproic Acid—Fatigue—Doxorubicin—uterine cancer	5.82e-05	0.000254	CcSEcCtD
Valproic Acid—Urticaria—Epirubicin—uterine cancer	5.79e-05	0.000253	CcSEcCtD
Valproic Acid—Pain—Doxorubicin—uterine cancer	5.77e-05	0.000252	CcSEcCtD
Valproic Acid—Constipation—Doxorubicin—uterine cancer	5.77e-05	0.000252	CcSEcCtD
Valproic Acid—Abdominal pain—Epirubicin—uterine cancer	5.77e-05	0.000252	CcSEcCtD
Valproic Acid—Body temperature increased—Epirubicin—uterine cancer	5.77e-05	0.000252	CcSEcCtD
Valproic Acid—Feeling abnormal—Doxorubicin—uterine cancer	5.56e-05	0.000243	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Doxorubicin—uterine cancer	5.52e-05	0.000241	CcSEcCtD
Valproic Acid—Hypersensitivity—Epirubicin—uterine cancer	5.37e-05	0.000235	CcSEcCtD
Valproic Acid—Urticaria—Doxorubicin—uterine cancer	5.36e-05	0.000234	CcSEcCtD
Valproic Acid—Abdominal pain—Doxorubicin—uterine cancer	5.33e-05	0.000233	CcSEcCtD
Valproic Acid—Body temperature increased—Doxorubicin—uterine cancer	5.33e-05	0.000233	CcSEcCtD
Valproic Acid—Asthenia—Epirubicin—uterine cancer	5.23e-05	0.000228	CcSEcCtD
Valproic Acid—Pruritus—Epirubicin—uterine cancer	5.16e-05	0.000225	CcSEcCtD
Valproic Acid—Diarrhoea—Epirubicin—uterine cancer	4.99e-05	0.000218	CcSEcCtD
Valproic Acid—Hypersensitivity—Doxorubicin—uterine cancer	4.97e-05	0.000217	CcSEcCtD
Valproic Acid—Asthenia—Doxorubicin—uterine cancer	4.84e-05	0.000211	CcSEcCtD
Valproic Acid—Dizziness—Epirubicin—uterine cancer	4.82e-05	0.00021	CcSEcCtD
Valproic Acid—Pruritus—Doxorubicin—uterine cancer	4.77e-05	0.000208	CcSEcCtD
Valproic Acid—Vomiting—Epirubicin—uterine cancer	4.64e-05	0.000202	CcSEcCtD
Valproic Acid—Diarrhoea—Doxorubicin—uterine cancer	4.62e-05	0.000202	CcSEcCtD
Valproic Acid—Rash—Epirubicin—uterine cancer	4.6e-05	0.000201	CcSEcCtD
Valproic Acid—Dermatitis—Epirubicin—uterine cancer	4.59e-05	0.000201	CcSEcCtD
Valproic Acid—Headache—Epirubicin—uterine cancer	4.57e-05	0.000199	CcSEcCtD
Valproic Acid—Dizziness—Doxorubicin—uterine cancer	4.46e-05	0.000195	CcSEcCtD
Valproic Acid—Nausea—Epirubicin—uterine cancer	4.33e-05	0.000189	CcSEcCtD
Valproic Acid—Vomiting—Doxorubicin—uterine cancer	4.29e-05	0.000187	CcSEcCtD
Valproic Acid—Rash—Doxorubicin—uterine cancer	4.26e-05	0.000186	CcSEcCtD
Valproic Acid—Dermatitis—Doxorubicin—uterine cancer	4.25e-05	0.000186	CcSEcCtD
Valproic Acid—Headache—Doxorubicin—uterine cancer	4.23e-05	0.000185	CcSEcCtD
Valproic Acid—Nausea—Doxorubicin—uterine cancer	4.01e-05	0.000175	CcSEcCtD
Valproic Acid—UGT2B7—Metabolism—CYP19A1—uterine cancer	2.06e-05	0.000192	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—KRAS—uterine cancer	2.05e-05	0.000191	CbGpPWpGaD
Valproic Acid—HDAC2—Gene Expression—ESR1—uterine cancer	2.04e-05	0.00019	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—RRM2—uterine cancer	2.02e-05	0.000189	CbGpPWpGaD
Valproic Acid—OGDH—Metabolism—AKT1—uterine cancer	2.01e-05	0.000188	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—AKR1B1—uterine cancer	2e-05	0.000186	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—STAR—uterine cancer	2e-05	0.000186	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—STK11—uterine cancer	1.98e-05	0.000185	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.98e-05	0.000184	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—DCN—uterine cancer	1.97e-05	0.000183	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—CTNNB1—uterine cancer	1.96e-05	0.000183	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—MTHFR—uterine cancer	1.95e-05	0.000182	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—PIK3CA—uterine cancer	1.93e-05	0.000179	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—SRD5A2—uterine cancer	1.92e-05	0.000179	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—NDUFB11—uterine cancer	1.92e-05	0.000179	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—RRM2—uterine cancer	1.91e-05	0.000178	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—PTEN—uterine cancer	1.91e-05	0.000178	CbGpPWpGaD
Valproic Acid—UGT2B15—Metabolism—PTEN—uterine cancer	1.89e-05	0.000176	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—PIK3CA—uterine cancer	1.89e-05	0.000176	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—KRAS—uterine cancer	1.88e-05	0.000175	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	1.87e-05	0.000174	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—DCN—uterine cancer	1.86e-05	0.000173	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—SOCS3—uterine cancer	1.86e-05	0.000173	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—POLD1—uterine cancer	1.85e-05	0.000173	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—CYP11A1—uterine cancer	1.85e-05	0.000173	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—TP53—uterine cancer	1.83e-05	0.00017	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—EP300—uterine cancer	1.82e-05	0.00017	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—MTHFR—uterine cancer	1.82e-05	0.000169	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—POLD1—uterine cancer	1.81e-05	0.000169	CbGpPWpGaD
Valproic Acid—UGT2B15—Metabolism—EP300—uterine cancer	1.8e-05	0.000168	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—STAR—uterine cancer	1.78e-05	0.000166	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—AKR1B1—uterine cancer	1.78e-05	0.000166	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—HRAS—uterine cancer	1.78e-05	0.000166	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CDKN2B—uterine cancer	1.78e-05	0.000166	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	1.76e-05	0.000164	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.76e-05	0.000164	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—CYP11A1—uterine cancer	1.75e-05	0.000163	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—AKR1C3—uterine cancer	1.75e-05	0.000163	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—HRAS—uterine cancer	1.75e-05	0.000163	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—AKR1C1—uterine cancer	1.73e-05	0.000161	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—VEGFA—uterine cancer	1.73e-05	0.000161	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—IGF1R—uterine cancer	1.73e-05	0.000161	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—PIK3CA—uterine cancer	1.73e-05	0.000161	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—NRAS—uterine cancer	1.71e-05	0.000159	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—AKR1C1—uterine cancer	1.69e-05	0.000158	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—STK11—uterine cancer	1.67e-05	0.000156	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—CYP19A1—uterine cancer	1.67e-05	0.000156	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—TP53—uterine cancer	1.67e-05	0.000156	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—AKR1C3—uterine cancer	1.65e-05	0.000154	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—AKR1B1—uterine cancer	1.63e-05	0.000152	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—STAR—uterine cancer	1.63e-05	0.000152	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—SMAD3—uterine cancer	1.62e-05	0.000151	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.61e-05	0.00015	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—HRAS—uterine cancer	1.6e-05	0.000149	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—MTHFR—uterine cancer	1.59e-05	0.000148	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—PTEN—uterine cancer	1.58e-05	0.000147	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—AKT1—uterine cancer	1.57e-05	0.000147	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.57e-05	0.000146	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—POLD1—uterine cancer	1.57e-05	0.000146	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—FGFR2—uterine cancer	1.55e-05	0.000144	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—MTHFR—uterine cancer	1.55e-05	0.000144	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—RRM2—uterine cancer	1.54e-05	0.000144	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—AKT1—uterine cancer	1.54e-05	0.000144	CbGpPWpGaD
Valproic Acid—UGT1A8—Metabolism—PIK3CA—uterine cancer	1.52e-05	0.000142	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—RRM2—uterine cancer	1.51e-05	0.000141	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—EP300—uterine cancer	1.5e-05	0.00014	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—DCN—uterine cancer	1.5e-05	0.00014	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.5e-05	0.000139	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—NDUFB11—uterine cancer	1.48e-05	0.000138	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—SRD5A2—uterine cancer	1.48e-05	0.000138	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—KRAS—uterine cancer	1.47e-05	0.000137	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—AKR1C1—uterine cancer	1.47e-05	0.000137	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—DCN—uterine cancer	1.47e-05	0.000137	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—CYP11A1—uterine cancer	1.41e-05	0.000132	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—AKT1—uterine cancer	1.41e-05	0.000131	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—POLD1—uterine cancer	1.4e-05	0.00013	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—AKR1B1—uterine cancer	1.39e-05	0.00013	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—STAR—uterine cancer	1.39e-05	0.00013	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—ERBB2—uterine cancer	1.39e-05	0.000129	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—CYP11A1—uterine cancer	1.38e-05	0.000129	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.37e-05	0.000128	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—STK11—uterine cancer	1.36e-05	0.000127	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—CYP19A1—uterine cancer	1.36e-05	0.000127	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—PIK3CA—uterine cancer	1.35e-05	0.000126	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—AKR1C3—uterine cancer	1.33e-05	0.000124	CbGpPWpGaD
Valproic Acid—UGT2B15—Metabolism—PIK3CA—uterine cancer	1.33e-05	0.000124	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—ESR1—uterine cancer	1.32e-05	0.000123	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—AKR1C1—uterine cancer	1.31e-05	0.000122	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—RRM2—uterine cancer	1.31e-05	0.000122	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—TP53—uterine cancer	1.31e-05	0.000122	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—AKR1C3—uterine cancer	1.3e-05	0.000122	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—CYP19A1—uterine cancer	1.29e-05	0.00012	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—STK11—uterine cancer	1.29e-05	0.00012	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—CDKN1B—uterine cancer	1.29e-05	0.00012	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.28e-05	0.000119	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—POLD1—uterine cancer	1.28e-05	0.000119	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—DCN—uterine cancer	1.27e-05	0.000118	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—MTHFR—uterine cancer	1.26e-05	0.000117	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—HRAS—uterine cancer	1.25e-05	0.000116	CbGpPWpGaD
Valproic Acid—UGT1A8—Metabolism—AKT1—uterine cancer	1.24e-05	0.000116	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.22e-05	0.000114	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—PTEN—uterine cancer	1.22e-05	0.000113	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—CTNNB1—uterine cancer	1.21e-05	0.000113	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—CYP11A1—uterine cancer	1.2e-05	0.000111	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—AKR1C1—uterine cancer	1.19e-05	0.000111	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—PTEN—uterine cancer	1.18e-05	0.00011	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—RRM2—uterine cancer	1.17e-05	0.000109	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CCL2—uterine cancer	1.17e-05	0.000109	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—EP300—uterine cancer	1.16e-05	0.000108	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—DCN—uterine cancer	1.13e-05	0.000106	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—AKR1C3—uterine cancer	1.13e-05	0.000105	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—EP300—uterine cancer	1.13e-05	0.000105	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—PIK3CA—uterine cancer	1.11e-05	0.000104	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.11e-05	0.000103	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—AKT1—uterine cancer	1.1e-05	0.000103	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—POLD1—uterine cancer	1.09e-05	0.000102	CbGpPWpGaD
Valproic Acid—UGT2B15—Metabolism—AKT1—uterine cancer	1.09e-05	0.000101	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—PTEN—uterine cancer	1.08e-05	0.000101	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—AKR1B1—uterine cancer	1.07e-05	0.0001	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—STAR—uterine cancer	1.07e-05	0.0001	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—CYP11A1—uterine cancer	1.07e-05	9.95e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—RRM2—uterine cancer	1.06e-05	9.92e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—NRAS—uterine cancer	1.06e-05	9.84e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—STK11—uterine cancer	1.04e-05	9.69e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—CYP19A1—uterine cancer	1.04e-05	9.69e-05	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—EP300—uterine cancer	1.03e-05	9.63e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—DCN—uterine cancer	1.03e-05	9.63e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—MTHFR—uterine cancer	1.02e-05	9.54e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—AKR1C1—uterine cancer	1.02e-05	9.51e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—STK11—uterine cancer	1.02e-05	9.47e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—CYP19A1—uterine cancer	1.02e-05	9.47e-05	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—PTEN—uterine cancer	1.01e-05	9.42e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—AKR1C3—uterine cancer	1.01e-05	9.39e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—CYP11A1—uterine cancer	9.73e-06	9.07e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—ERBB2—uterine cancer	9.72e-06	9.06e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—MTHFR—uterine cancer	9.68e-06	9.02e-05	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—EP300—uterine cancer	9.64e-06	8.99e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CXCL8—uterine cancer	9.22e-06	8.59e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—AKR1C3—uterine cancer	9.19e-06	8.57e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—RRM2—uterine cancer	9.1e-06	8.47e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—KRAS—uterine cancer	9.09e-06	8.47e-05	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—AKT1—uterine cancer	9.08e-06	8.46e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	9.02e-06	8.41e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CDKN1B—uterine cancer	9.01e-06	8.39e-05	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—PTEN—uterine cancer	8.84e-06	8.24e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—DCN—uterine cancer	8.83e-06	8.23e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—STK11—uterine cancer	8.8e-06	8.2e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—CYP19A1—uterine cancer	8.8e-06	8.2e-05	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—PTEN—uterine cancer	8.6e-06	8.01e-05	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—PIK3CA—uterine cancer	8.58e-06	8e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CTNNB1—uterine cancer	8.51e-06	7.93e-05	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—EP300—uterine cancer	8.43e-06	7.85e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—POLD1—uterine cancer	8.42e-06	7.85e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—PIK3CA—uterine cancer	8.35e-06	7.78e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—CYP11A1—uterine cancer	8.32e-06	7.75e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—PTEN—uterine cancer	8.29e-06	7.73e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	8.26e-06	7.7e-05	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—EP300—uterine cancer	8.2e-06	7.64e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—EP300—uterine cancer	7.91e-06	7.37e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—EP300—uterine cancer	7.88e-06	7.34e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—AKR1C1—uterine cancer	7.88e-06	7.34e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—AKR1C3—uterine cancer	7.86e-06	7.32e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—STK11—uterine cancer	7.85e-06	7.32e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—CYP19A1—uterine cancer	7.85e-06	7.32e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—MTHFR—uterine cancer	7.81e-06	7.28e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—HRAS—uterine cancer	7.73e-06	7.2e-05	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—PIK3CA—uterine cancer	7.65e-06	7.13e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—MTHFR—uterine cancer	7.63e-06	7.11e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—VEGFA—uterine cancer	7.49e-06	6.98e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—NRAS—uterine cancer	7.4e-06	6.89e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	7.37e-06	6.87e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Gene Expression—AKT1—uterine cancer	7.35e-06	6.85e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—CYP19A1—uterine cancer	7.16e-06	6.67e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—STK11—uterine cancer	7.16e-06	6.67e-05	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—PIK3CA—uterine cancer	7.13e-06	6.65e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—EP300—uterine cancer	7.03e-06	6.55e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—RRM2—uterine cancer	7.02e-06	6.54e-05	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—AKT1—uterine cancer	7.01e-06	6.53e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—PTEN—uterine cancer	6.99e-06	6.51e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—AKT1—uterine cancer	6.82e-06	6.36e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—DCN—uterine cancer	6.81e-06	6.35e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	6.72e-06	6.26e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—EP300—uterine cancer	6.66e-06	6.21e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—MTHFR—uterine cancer	6.61e-06	6.16e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—CYP11A1—uterine cancer	6.42e-06	5.98e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	6.41e-06	5.97e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—KRAS—uterine cancer	6.37e-06	5.93e-05	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—AKT1—uterine cancer	6.25e-06	5.82e-05	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—PIK3CA—uterine cancer	6.24e-06	5.81e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—STK11—uterine cancer	6.12e-06	5.7e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—CYP19A1—uterine cancer	6.12e-06	5.7e-05	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—PIK3CA—uterine cancer	6.07e-06	5.65e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—AKR1C3—uterine cancer	6.06e-06	5.65e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—MTHFR—uterine cancer	5.9e-06	5.5e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—PIK3CA—uterine cancer	5.85e-06	5.45e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	5.83e-06	5.43e-05	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—AKT1—uterine cancer	5.83e-06	5.43e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	5.75e-06	5.35e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—PTEN—uterine cancer	5.7e-06	5.31e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—TP53—uterine cancer	5.66e-06	5.27e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	5.48e-06	5.11e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—EP300—uterine cancer	5.43e-06	5.06e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—HRAS—uterine cancer	5.41e-06	5.04e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—PTEN—uterine cancer	5.39e-06	5.02e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—MTHFR—uterine cancer	5.38e-06	5.01e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	5.2e-06	4.85e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—EP300—uterine cancer	5.14e-06	4.79e-05	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—AKT1—uterine cancer	5.09e-06	4.75e-05	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—AKT1—uterine cancer	4.96e-06	4.62e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—PIK3CA—uterine cancer	4.93e-06	4.59e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—AKT1—uterine cancer	4.78e-06	4.45e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	4.74e-06	4.42e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—CYP19A1—uterine cancer	4.72e-06	4.4e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—STK11—uterine cancer	4.72e-06	4.4e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—MTHFR—uterine cancer	4.6e-06	4.29e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—PTEN—uterine cancer	4.35e-06	4.05e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—PTEN—uterine cancer	4.25e-06	3.96e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—EP300—uterine cancer	4.14e-06	3.86e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	4.05e-06	3.78e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—EP300—uterine cancer	4.05e-06	3.77e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—AKT1—uterine cancer	4.03e-06	3.75e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—PIK3CA—uterine cancer	4.02e-06	3.74e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—PIK3CA—uterine cancer	3.8e-06	3.54e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—PTEN—uterine cancer	3.68e-06	3.43e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—MTHFR—uterine cancer	3.55e-06	3.31e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—EP300—uterine cancer	3.51e-06	3.27e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—PTEN—uterine cancer	3.28e-06	3.06e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—AKT1—uterine cancer	3.28e-06	3.06e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—EP300—uterine cancer	3.13e-06	2.92e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—AKT1—uterine cancer	3.1e-06	2.89e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—PIK3CA—uterine cancer	3.07e-06	2.86e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—PIK3CA—uterine cancer	3e-06	2.79e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PTEN—uterine cancer	2.99e-06	2.79e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—EP300—uterine cancer	2.86e-06	2.66e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—PIK3CA—uterine cancer	2.6e-06	2.42e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PTEN—uterine cancer	2.56e-06	2.38e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—AKT1—uterine cancer	2.5e-06	2.33e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—AKT1—uterine cancer	2.45e-06	2.28e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—EP300—uterine cancer	2.44e-06	2.27e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—PIK3CA—uterine cancer	2.32e-06	2.16e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—AKT1—uterine cancer	2.12e-06	1.98e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PIK3CA—uterine cancer	2.11e-06	1.97e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PTEN—uterine cancer	1.97e-06	1.84e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—AKT1—uterine cancer	1.89e-06	1.76e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—EP300—uterine cancer	1.88e-06	1.75e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PIK3CA—uterine cancer	1.81e-06	1.68e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—AKT1—uterine cancer	1.73e-06	1.61e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—AKT1—uterine cancer	1.47e-06	1.37e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PIK3CA—uterine cancer	1.39e-06	1.3e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—AKT1—uterine cancer	1.14e-06	1.06e-05	CbGpPWpGaD
